Drug release from an ophthalmic insert of a beta-blocker as an ocular drug delivery system
- 30 November 1993
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 27 (2) , 127-137
- https://doi.org/10.1016/0168-3659(93)90216-r
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Kinetics of drug release from hydrogel matricesPublished by Elsevier ,2002
- Modification of ocular and systemic absorption of timolol from ocular inserts by a buffering agent and a vasoconstrictorInternational Journal of Pharmaceutics, 1990
- Liposomal ophthalmic drug delivery. III. Pharmacodynamic and biodisposition studies of atropineInternational Journal of Pharmaceutics, 1989
- Improvement of Systemic Absorption of Insulin Through Eyes with Absorption EnhancersJournal of Pharmaceutical Sciences, 1989
- Distribution of poly-hexyl-2-cyano-[3-14C]acrylate nanoparticles in healthy and chronically inflamed rabbit eyesInternational Journal of Pharmaceutics, 1989
- Solution viscosity effects on the ocular disposition of cromolyn sodium in the albino rabbitInternational Journal of Pharmaceutics, 1989
- Swelling controlled-release systems: recent developments and applicationsInternational Journal of Pharmaceutics, 1988
- Efficacy of a liposome preparation of anti-inflammatory steroid as an ocular drug-delivery system.Journal of Pharmacobio-Dynamics, 1988
- A simple equation for description of solute release II. Fickian and anomalous release from swellable devicesJournal of Controlled Release, 1987
- Ocular therapy with nanoparticulate systems for controlled drug deliveryJournal of Controlled Release, 1985